Osteoarthritis and Bone Disorders News

Adults, particularly those with a low income and aged at least 65 years, have an increased risk for bone fracture and osteoporosis-related loss of bone mineral density with long-term exposure to air pollution, according to findings published in The Lancet Planetary Health.

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Robin K. Dore, MD, spoke about results of the ACTIVExtend trial of postmenopausal women with osteoporosis. She said results showed that women who received abaloparatide for 18 months followed by 24 months of alendronate had a sustained decrease of vertebral and nonvertebral fractures compared to women who received placebo followed by alendronate.

SAN DIEGO — Thirty percent of patients with end-stage knee, hip or spine osteoarthritis used opioids to manage chronic pain before surgery, according to data presented at the American College of Rheumatology Annual Meeting.

The U.S. Preventive Services Task Force has issued draft recommendations that clinicians screen all women age older than 65 years for osteoporosis as well as postmenopausal women younger than 65 years who are at increased risk for osteoporosis. The task force gave these recommendations a ‘B’ grade.

SAN DIEGO — Patients with rheumatoid arthritis are at higher risk for osteoporotic fractures if they are taking opioids or selective serotonin reuptake inhibitors, according to data from a press release issued at the American College of Rheumatology Annual Meeting.

Women who discontinued use of bisphosphates for more than 2 years after long-term use were up to 39% more likely to have hip fractures compared to those who continued treatment, according to findings presented at the American College of Rheumatology Annual Meeting.

Although chondrocalcinosis appears to be associated with increased pain, knees affected by chondrocalcinosis do not have higher synovitis scores on MRI vs. knees without chondrocalcinosis, according to results.

Use of different radiographic views appears to increase the frequency of radiographic osteoarthritis detection, according to results from the CHECK study.

Results published in The Journal of Arthroplasty showed patients with knee osteoarthritis who received either low-, moderate- or high-molecular-weight hyaluronic acid injections had no significant differences in the likelihood of surgical interventions.

Although overweight and obese patients who undergo knee replacement may lose weight in the period before and immediately following surgery, they are less likely to lose more than 2.5% of their body weight in the ensuing 1 year to 2 years, according to findings.